journal
MENU ▼
Read by QxMD icon Read
search

Dermatology Reports

journal
https://read.qxmd.com/read/30815242/trps1-deficient-transplanted-skin-gave-rise-to-a-substantial-amount-of-hair-trps1-is-unnecessary-for-hair-development
#1
Yingzhe Zhang, Tomoyuki Nakamura, Fukumi Furukawa, Yasuteru Muragaki
Trps1 is considered as an important gene involved in the interactions between the epithelial and mesenchymal cells during hair follicle morphogenesis. The number of hair follicles in Trps1 Knockout (KO) newborn mouse skin was significantly lower than that in wild-type (WT) newborn skin. To gain insight into the functional role of Trps1 in hair development, we transplanted Trps1 KO newborn mouse skin on the backs of nude mice and examined hair growth at day 42 after transplantation. Surprisingly, transplanted skin from Trps1 KO newborn mice gave rise to a substantial amount of hair, although the hair was softer than that of WT mice...
January 23, 2019: Dermatology Reports
https://read.qxmd.com/read/30603060/histopathological-and-patient-related-characteristics-of-basal-cell-carcinomas-of-the-head-and-neck-influencing-therapeutic-management
#2
Henrik Holtmann, Vera Fuhrmann, Karoline Sander, Christoph Sproll, Norbert R Kübler, Daman Deep Singh, Julian Lommen
The authors hypothesize that histopathological characteristics of basal cell carcinomas of the head and neck (BCCHN) have changed over time and the correlation of BCCHN localization and histological tumour type can help improving the number and quality of necessary therapeutic interventions. Information of 222 patients with 344 BCCHN was gained. Descriptive measures were compared to prior studies to prove whether or not characteristics of basal cell carcinomas or patients have changed over time. Afterwards descriptive measures were correlated with number of conducted operations to evaluate if tumour localization, histological tumour type and number of operations depend on one another...
October 1, 2018: Dermatology Reports
https://read.qxmd.com/read/30555667/lupus-pernio-besnier-tenneson-syndrome-a-rare-form-of-sarcoidosis
#3
Amal Hubail, Roza Belkharoeva, Natalya Tepluk, Tatyana Belerosova
Lupus pernio (LP) is a chronic non-life threatining type of cutaneous sarcoidosis that can be related to chronic fibrotic sarcoidosis, hyperglobulinemia and hypercalcemia. The aim of this case report is to evaluate the clinical and demographic features of cutaneous sarcoidosis mainly presenting with a rare manifestation of LP. In this paper we report a case of systemic sarcoidosis presenting with LP and a review of the available literature. LP is a rare presentation with infiltrated erythematoviolaceous plaques affecting the nose...
October 1, 2018: Dermatology Reports
https://read.qxmd.com/read/30555666/antioxidant-properties-of-topical-caulerpa-sp-extract-on-uvb-induced-photoaging-in-mice
#4
Anak Agung Gde Putra Wiraguna, Wimpie Pangkahila, I Nyoman Mantik Astawa
Caulerpa sp. , a genus of seaweed native to the Indo-Pacific region, has been known for its antioxidant properties and health benefits when consumed as food. Previous studies have reported Caulerpa sp. 's potential as a strong antioxidant, but its effects on the skin in a topical preparation, especially its role in ultraviolet (UV) protection, have not been studied extensively. Our study investigated the protective effects of 0.2% and 0.4% Caulerpa sp. extract gels on photoaging in the UVB-irradiated skin of Wistar mice...
October 1, 2018: Dermatology Reports
https://read.qxmd.com/read/30464809/cephalexin-induced-acute-generalized-exanthematous-pustulosis
#5
Matthew DaCunha, Sarah Moore, David Kaplan
Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associating cephalexin with AGEP in hopes that clinicians will consider AGEP in their differential diagnosis in the appropriate clinical setting.
October 1, 2018: Dermatology Reports
https://read.qxmd.com/read/30370041/efficacy-of-adalimumab-in-moderate-to-severe-hidradenitis-suppurativa-real-life-data
#6
Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi
Hidradenitis suppurativa (HS) is a relapsing, inflammatory disease characterized by painful nodules, abscesses, sinuses track formation and scarring. HS has a great impact on patients' quality of life and its treatment may be really challenging. Adalimumab provides a new therapeutic option for HS. Our aim was to assess the therapeutic potential of adalimumab on patients with HS based on the data from the daily clinical practice of an HS Outpatient Clinic. 19 patients with clinically evident moderate to severe HS, under adalimumab treatment for at least 24 week, participated in this observational, retrospective study...
October 1, 2018: Dermatology Reports
https://read.qxmd.com/read/29991980/foscarnet-induced-genital-lesions-an-overview-with-a-case-report
#7
Jonas A Adalsteinsson, Michael Pan, Shivani Kaushik, Jonathan Ungar
Foscarnet is an important antiviral medication used mainly in the treatment of complicated Herpes-simplex virus and cytomegalovirus (CMV) infections. Reported first in the 1990's, genital ulcers are a potential side effect in about 10% of cases. We report the case of a 29 year old man with acute myelogenous leukemia who was on ganciclovir for CMV prophylaxis. Three weeks after being switched to foscarnet because of neutropenia, he developed two, painful symmetric ulcers on the inferior aspect of glans penis...
April 23, 2018: Dermatology Reports
https://read.qxmd.com/read/29991979/hidradenitis-suppurativa-in-a-patient-with-hyperandrogenism-insulin-resistance-and-acanthosis-nigricans-hair-an-syndrome
#8
Yaser Taha Melibary
The author reports a rare presentation of hidradenitis supprutiva (HS) in combination with hyperandrogenism, insulin-resistance and acanthosis nigricans (HAIR-AN syndrome) in a female patient. Recently many clues have improved the understanding of HS as a systemic disease rather as a disease only with dermatological manifestation. This report might give another hint emphasizing the endocrinological and hormonal role in HS.
April 23, 2018: Dermatology Reports
https://read.qxmd.com/read/29991978/a-case-of-lipomembranous-panniculitis-with-a-dramatic-response-to-the-treatment-of-venous-insufficiency
#9
Didem Mullaaziz, Aslı Kaptanoğlu, Emel Erdal Çalıkoğlu, Hanife Özkayalar
Lipomembranous panniculitis (LP) is a peculiar type of fat necrosis and is reported with various clinical conditions, mostly with peripheral vascular diseases. Here, a case of a 57-year-old woman with a painful erythematous swelling of the right leg in association with venous insufficiency has been reported. Although LP is frequently associated with venous insufficiency, to the best of our knowledge, this is the first report on the beneficial effect of venous insufficiency treatment in LP.
April 23, 2018: Dermatology Reports
https://read.qxmd.com/read/29887980/a-case-of-chronic-ulcer-due-to-subcutaneous-arteriolosclerosis-in-an-obese-patient-mimicking-pyoderma-gangrenosum
#10
Sezin Fıçıcıoğlu, Nuray Can, Busem Tutuğ
The differential diagnosis of chronic ulcers covers a wide range of diseases and poses a diagnostic challenge. Subcutaneous ischemic arteriolosclerosis can lead to local ischaemia and ulceration as a result of arteriolar narrowing and reduction of tissue perfusion. This pathophysiological feature can be seen in eutrophication (nonuremic calciphylaxis) in morbid obesity, hypertensive ischemic leg ulcer (Martorell ulcer) and calciphylaxis in chronic renal insufficiency. All of the ulcers happened in this way can be wrongly diagnosed as pyoderma gangrenosum because of clinical similarity and inadequate biopsies...
April 23, 2018: Dermatology Reports
https://read.qxmd.com/read/29774138/clinical-evaluation-of-morgellons-disease-in-a-cohort-of-north-american-patients
#11
Melissa C Fesler, Marianne J Middelveen, Raphael B Stricker
Morgellons disease (MD) is a dermatological condition characterized by aberrant production of keratin and collagen fibers in skin. Although infection with Borrelia burgdorferi , the causative agent of Lyme disease (LD), has been associated with MD, relatively few studies have hitherto provided epidemiological evidence regarding this association. A cohort of 1000 seropositive North American LD patients was evaluated for the presence of MD. Patients were diagnosed with MD based on detection of microscopic fibers in skin lesions or under unbroken skin...
April 23, 2018: Dermatology Reports
https://read.qxmd.com/read/29760873/early-morphea-simulating-patch-stage-mycosis-fungoides-in-two-cases
#12
Hamid R Ghasemi Basir, Pedram Alirezaei, Aliasghar Rezanejad, Sajjad Daneshyar
Morphea is a skin disorder characterized by thickening of dermis and subcutaneous tissues and loss of adnexal structures. In the early inflammatory stage of morphea, diagnostic histological findings are absent and this may lead to confusion with other inflammatory dermatoses such as mycosis fungoides (MF). We report two cases of early stage morphea mimicking patchstage of MF. Histopathologic examination of biopsies obtained early in the disease course revealed lymphocytic epidermotropism arranged in small pautrier-like collections as well as linear arrangements in dermal- epidermal junction...
April 23, 2018: Dermatology Reports
https://read.qxmd.com/read/29430289/quality-of-life-in-patients-with-melasma-in-turkish-women
#13
Hacer Uyanikoglu, Mustafa Aksoy
No abstract text is available yet for this article.
October 11, 2017: Dermatology Reports
https://read.qxmd.com/read/29299216/a-retrospective-comparative-study-of-the-efficacy-and-safety-of-two-regimens-of-diphenylcyclopropenone-in-the-treatment-of-recalcitrant-alopecia-areata
#14
Tueboon Sriphojanart, Saranya Khunkhet, Poonkiat Suchonwanit
Diphenylcyclopropenone (DPCP) is an effective topical immunotherapy for recalcitrant alopecia areata (AA), which sometimes requires prolonged treatment. We developed a new treatment protocol to shorten the duration of therapy. This study aimed to compare the efficacy and safety of the new treatment protocol with the standard treatment protocol in the treatment of recalcitrant AA. We conducted a 6-year retrospective comparative study of patients with AA who received one of the DPCP treatment protocols at our institute...
October 11, 2017: Dermatology Reports
https://read.qxmd.com/read/29279772/combination-of-negative-pressure-wound-therapy-and-systemic-steroid-therapy-in-postsurgical-pyoderma-gangrenosum-after-reduction-mammoplasty-a-case-of-proven-efficacy-and-safety
#15
Sara Tanini, Gianmarco Calugi, Giulia Lo Russo
No abstract text is available yet for this article.
October 11, 2017: Dermatology Reports
https://read.qxmd.com/read/29142660/considering-the-hypothesis-of-the-pathophysiology-of-cellulite-in-its-treatment
#16
José Maria Pereira de Godoy, Ana Carolina Pereira de Godoy, Maria de Fatima Guerreiro Godoy
No abstract text is available yet for this article.
October 11, 2017: Dermatology Reports
https://read.qxmd.com/read/29090075/lentiginous-eruption-in-resolving-psoriasis-plaques-during-treatment-with-ixekizumab-a-case-report-and-review-of-the-literature
#17
Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen
No abstract text is available yet for this article.
October 11, 2017: Dermatology Reports
https://read.qxmd.com/read/29142659/actinic-prurigo-in-scandinavian-adolescent-successfully-treated-with-cyclosporine-a
#18
Jan C Sitek
Actinic prurigo is a pruritic sun-induced dermatosis classified among the immunologically mediated photodermatoses. The disease is a well-known entity among Native Americans and in Central and South America, however rare in Caucasians with only a few reports from Australia, Britain and France. We report the first case of actinic prurigo in a Scandinavian patient, responding favorably to systemic treatment with cyclosporine A.
March 13, 2017: Dermatology Reports
https://read.qxmd.com/read/28652908/case-histories-of-intense-pulsed-light-phototherapy-in-dermatology-the-hppl%C3%A2-and-ifl-%C3%A2-technologies
#19
Alessandro Martella, Mauro Raichi
The intense pulsed light (IPL) and laser technologies are widely used for skin rejuvenation and for treating several dermatological disorders such as skin dyschromia and acne, and for non-ablative dermal remodeling of rhytides and hypertrophic scars. Technological evolution is rapid. The High Power Pulsed Light™ [HPPL™] and Incoherent Fast Light™ technologies [IFL™, Novavision Group S.p.A., 20826 Misinto (MB), Italy] are recent innovations in the field of IPL technologies; IFL™ is a further evolution of the already advanced HPPL™ system...
March 13, 2017: Dermatology Reports
https://read.qxmd.com/read/28652907/a-study-case-in-photoepilation-the-hppl-%C3%A2-and-ifl-%C3%A2-technologies
#20
Alessandro Martella, Mauro Raichi
The High Power Pulsed Light™ [HPPL™] and Incoherent Fast Light™ technologies [IFL™, Novavision Group S.p.A., 20826 Misinto (MB), Italy] are recent innovations in the field of unwanted hair removal with intense pulsed light devices. IFL™ is a further improvement over the already advanced characteristics of the HPPL™ technology. A selection of photoepilation case histories with the HPPL™ and IFL™ technologies is presented; a short introduction highlights the main features of the two technologies...
March 13, 2017: Dermatology Reports
journal
journal
49119
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"